22
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      HELQ promotes RAD51 paralog-dependent repair to avert germ cell attrition and tumourigenesis

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Repair of interstrand crosslinks (ICLs) requires the coordinate action of the intra-S phase checkpoint and the Fanconi Anemia (FA) pathway, which promote ICL incision, translesion synthesis, and homologous recombination (reviewed in 1, 2 ). Previous studies have implicated the 3′-5′ superfamily 2 helicase HELQ/Hel308 in ICL repair in D. melanogaster (known as Mus301 or Spn-C 3 ) and C. elegans (known as Helq-1 or Hel-308 4 ). While in vitro analysis suggests that HELQ preferentially unwinds synthetic replication fork substrates with 3′ ssDNA overhangs and also disrupts protein/DNA interactions while translocating along DNA 5, 6 , little is known regarding its functions in mammalian organisms. Here we report that HELQ helicase-deficient mice exhibit subfertility, germ cell attrition, ICL sensitivity and tumour predisposition, with HelQ heterozygous mice exhibiting a similar, albeit less severe, phenotype than the null, indicative of haploinsufficiency. We establish that HELQ interacts directly with the RAD51 paralog complex, BCDX2, and functions in parallel to the FA pathway to promote efficient HR at damaged replication forks. Thus, our results reveal a critical role for HELQ in replication-coupled DNA repair, germ cell maintenance and tumour suppression in mammals.

          Related collections

          Most cited references28

          • Record: found
          • Abstract: found
          • Article: not found

          Mutation of the RAD51C gene in a Fanconi anemia-like disorder.

          Fanconi anemia (FA) is a rare chromosomal-instability disorder associated with a variety of developmental abnormalities, bone marrow failure and predisposition to leukemia and other cancers. We have identified a homozygous missense mutation in the RAD51C gene in a consanguineous family with multiple severe congenital abnormalities characteristic of FA. RAD51C is a member of the RAD51-like gene family involved in homologous recombination-mediated DNA repair. The mutation results in loss of RAD51 focus formation in response to DNA damage and in increased cellular sensitivity to the DNA interstrand cross-linking agent mitomycin C and the topoisomerase-1 inhibitor camptothecin. Thus, biallelic germline mutations in a RAD51 paralog are associated with an FA-like syndrome.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Meta-analyses identify 13 novel loci associated with age at menopause and highlights DNA repair and immune pathways

            To identify novel loci for age at natural menopause, we performed a meta-analysis of 22 genome-wide association studies in 38,968 women of European descent, with replication in up to 14,435 women. In addition to four known loci, we identified 13 new age at natural menopause loci (P < 5 × 10−8). The new loci included genes implicated in DNA repair (EXO1, HELQ, UIMC1, FAM175A, FANCI, TLK1, POLG, PRIM1) and immune function (IL11, NLRP11, BAT2). Gene-set enrichment pathway analyses using the full GWAS dataset identified exodeoxyribonuclease, NFκB signalling and mitochondrial dysfunction as biological processes related to timing of menopause.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Bone marrow failure in Fanconi anemia is triggered by an exacerbated p53/p21 DNA damage response that impairs hematopoietic stem and progenitor cells.

              Fanconi anemia (FA) is an inherited DNA repair deficiency syndrome. FA patients undergo progressive bone marrow failure (BMF) during childhood, which frequently requires allogeneic hematopoietic stem cell transplantation. The pathogenesis of this BMF has been elusive to date. Here we found that FA patients exhibit a profound defect in hematopoietic stem and progenitor cells (HSPCs) that is present before the onset of clinical BMF. In response to replicative stress and unresolved DNA damage, p53 is hyperactivated in FA cells and triggers a late p21(Cdkn1a)-dependent G0/G1 cell-cycle arrest. Knockdown of p53 rescued the HSPC defects observed in several in vitro and in vivo models, including human FA or FA-like cells. Taken together, our results identify an exacerbated p53/p21 "physiological" response to cellular stress and DNA damage accumulation as a central mechanism for progressive HSPC elimination in FA patients, and have implications for clinical care. Copyright © 2012 Elsevier Inc. All rights reserved.
                Bookmark

                Author and article information

                Journal
                0410462
                6011
                Nature
                Nature
                Nature
                0028-0836
                1476-4687
                26 August 2013
                04 September 2013
                17 October 2013
                17 April 2014
                : 502
                : 7471
                : 10.1038/nature12565
                Affiliations
                [1 ]DNA Damage Response Laboratory, London Research Institute, Cancer Research UK, Clare Hall, South Mimms, EN6 3LD, UK
                [2 ]Center for Biological Sequence Analysis, Technical University of Denmark, Lyngby, Denmark
                [3 ]Institute of Molecular Cancer Research, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland
                [4 ]Department of Radiation Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, 02215, USA
                [5 ]Protein Analysis and Proteomics Laboratory, London Research Institute, Cancer Research UK, Clare Hall, South Mimms, EN6 3LD, UK
                [6 ]Experimental Histopathology Laboratory, London Research Institute, Cancer Research UK, 44 Lincoln’s Inn Fields, London, WC2A 3LY, UK
                [7 ]Translational Cancer Therapeutics Laboratory, London Research Institute, Cancer Research UK, 44 Lincoln’s Inn Fields, London, WC2A 3LY, UK
                [8 ]UCL Cancer Institute, Huntley Street, London, WC1E 6DD
                Author notes
                [^]

                Present address: Mass Spectrometry, Medical Research Council Laboratory of Molecular Biology, Hills Road, Cambridge, CB2 0QH, UK

                Statements

                C.A.A., R.L.L. & S.J.B. designed the study, performed experiments, and wrote the manuscript unless otherwise stated, G.S. performed mouse post-mortem analyses and advised on histopathology, O.M. & A.A.S. performed and supervised DR-GFP HR assays, K.M. performed RAD51 foci experiments, Z.H. performed human clonogenic survival assays, K.P. & A.D. performed and supervised mouse bone marrow experiments, V.B. assisted with mouse tumour watch monitoring, J.M.S. supervised mass spec, N.J.B. & C.S. advised on experiments and manuscript revisions, and all authors contributed to revision of the manuscript.

                Article
                EMS54511
                10.1038/nature12565
                3836231
                24005329
                b31fb290-65b3-4bf8-ab0b-826808e32a2d

                Users may view, print, copy, download and text and data- mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms

                History
                Funding
                Funded by: Cancer Research UK :
                Award ID: A3549 || CRUK_
                Categories
                Article

                Uncategorized
                Uncategorized

                Comments

                Comment on this article